Page 123 - 80_03

Cannabinoides…

11.
Ben
Amar,
M.
Cannabinoids
in
medicine:
A
review
of
their
therapeutic
potential.

J

Ethnopharmacol
,
105
(1-­-2),
1-­-25
(2006).

12.
Hosking,
R.
D.;
Zajicek,
J.
P.
Therapeutic
potential
of
cannabis
in
pain
medicine.
Br
J
Anaesth

101
(1),
59-­-68
(2008).

13.
Pandey,
R.;
Mousawy,
K.;
Nagarkatti,
M.;
Nagarkatti,
P.
Endocannabinoids
and
immune

regulation.
Pharmacol
Res,
60
(2),
85-­-92
(2009).

14.
Thakur,
G.
A.;
Duclos,
R.
I.
Jr;
Makriyannis,
A.
Natural
cannabinoids:
templates

15.
Matias,
I.
;
Di
Marzo,
V.
Endocannabinoid
synthesis
and
degradation,
and
their
regulation
in

the
framework
of
energy
balance.
J
Endocrinol
Invest,
29,
15-­-26.
(2006).

16.
Piomelli,
D.;
Giuffrida
A.
;
Calignano,
A.;
Rodríguez
de
Fonseca,
F.
The
endocannabinoid

system
as
a
target
for
therapeutic
drugs.
Trends
Pharmacol
Sci,
21
(6),
218-­-224
(2000).

17.
Felder,
C.C.;
Dickason-­-Chesterfield,
A.K.;
Moore,
S.
A.
Cannabinoids
biology:
the
search
for

new
therapeutic
targets.
Mol
Interv,
6
(3),
149-­-161.

18.
McFarland,
M.J.;
Barker,
E.L.
Anandamide
transport.
Pharmacol
Ther,
104
(2),
117-­-135

(2004).

19.
Guzmán,
M.;
Sánchez,
C.;
Galve-­-Roperh,
I.Control
of
the
cell
survival/death
by

cannabinoids.
J
Mol
Med
(Berl),
78
(11),
613-­-625
(2001).

20.
Hirst,
R.
A.;
Lambert,
D.
G.;
Notcutt,
W.
G.
Pharmacology
and
potential
therapeutic
uses
of

cannabis.
Br
J
Anaesth,
81
(1),
77-­-84
(1998).

21.
McAllister,
S.
D.;
Glass,
M.
CB1
and
CB2
receptor-­-mediated
signalling:
a
focus
on

endocannabinoids.
Prostaglandins
Leukot
Essent
Fatty
Acids,
66
(2-­-3),
161-­-171
(2002).

22.
Fine,
P.
G.;
Rosenfeld,
M.
J.
The
endocannabinoid
system,
cannabinoids,
and
pain.
Rambam

Maimonides
Med
J,
4
(4),
1-­-15
(2013).

23.
Velasco,
G;
Galve-­-Roperh,
I.;
Sánchez,
C.;
Blázquez,
C.;
Guzmán,
M.
Hypothesis:
cannabinoid

therapy
for
the
treatment
of
gliomas
?.
Neuropharmacology,
47
(3),
315-­-323
(2004).

24.
Velasco,
G.;
Galve-­-Roperh,
I.;
Sánchez
C,
Blázquez,
C.;
Haro,
A.;
Guzmán,
M.
Cannabinoids

and
ceramide:
two
lipids
acting
hand-­-by-­-hand.
Life
Sci,
77
(14),
1723-­-1731
(2005).

25.
Munro,
S.;
Thomas,
K.
L.;
Abu-­-Shaar,
M.
Molecular
characterization
of
a
peripheral
receptor

for
cannabinoids.
Nature,
365
(6441),
61-­-65
(1993).

26.
Herkenham,
M.;
Lynn,
A.
B.;
Johnson,
M.
R.;
Melvin,
L.S.;
De
Costa,
B.
R.;
Rice,
K.C.

Characterization
and
localization
of
cannabinoid
receptors
in
rat
brain:
a
quantitative
in

vitro
autoradiographic
study.
J
Neurosci,
11
(2),
563-­-583
(1991).

27.
Henstridge,
C.M.;
Balenga,
N.
A.;
Kargl,
J.;
Andradas,
C.;
Brown,
A.
J.;
Irving,
A.;
Sanchez,
C.;

Waldhoer,
M.
Minireview:
Recent
Developments
in
the
Physiology
and
Pathology
of
the

Lysophosphatidylinositol-­-Sensitive
Receptor
GPR55.
Mol
Endocrinol,
25
(11),
1835:1848

(2011)

28.
Sylantyev,
S.;
Jensen;
T.
P.;
Ross,
R.
A.;
Rusakov,
D.
A.
Cannabinoid
and

lysophosphatidylinositol
sensitive
receptor
GPR55
boosts
neurotransmitter
release
at

central
synapses.
Proc
Natl
Acad
Sci
USA,
110
(13),
5193-­-5198
(2013).

29.
Izzo,
A.
A.;
Borrelli,
F.;
Capasso,
R.;
Di
Marzo,
V.;
Mechoulam,
R.Non-­-psychotropic
plant

cannabinoids:
new
therapeutic
opportunities
from
an
ancient
herb.
Trends
Pharmacol

Sci,
30
(10),
515-­-527
(2009).

30.
Henstridge,
C.
M.
Off
target
cannabinoid
effects
mediated
by
GPR55.
Pharmacology,
89
(3-­-
4),
179-­-187
(2012).

31.
Ryberg,
E.;
Larsson,
N.;
Sjögren,
S.;
Hjorth,
S.;
Hermansson,
N.
O.;
Leonova,
J.;
Elebring,
T.;

Nilsson,
K.;
Drmota,
T.;
Greasley,
P.
J.
The
orphan
receptor
GPR55
is
a
novel
cannabinoid

receptor.
Br
J
Pharmacol,
152
(7),
1092-­-1101
(2007).

32.
Tominaga,
M.;
Tominaga,
T.
Structure
and
function
of
TRPV.
Pflugers
Arch,
451
(1),
143-­-
150
(2005).

33.
Kola,
B.;
Boscaro,
M.;
Rutter,
G.
A.;
Grossman,
A.
B.;
Korbonitis,
M.
Expanding
role
of
AMPK

in
endocrinology.
Trends
Endocrinol
Metab,
17
(5),
205-­-215
(2006).

34.
Van
Thuijl,
H.;
Kola,
B.;
Korbonits,
M.
Appetite
and
metabolic
effects
of
ghrelin
and

cannabinoids:
involvement
of
AMPactivated
protein
kinase.
Vitam
Horm,
77,
121-­-148

(2008).

35.
Porter,
A.
C.;
Felder,
C.
C.
The
endocannabinoid
nervous
system:
Unique
opportunities
for

therapeutic
intervention.
Pharmacol
Ther,
90
(1),
45-­-60
(2001).

36.
Solinas,
M.;
Goldberg,
S.
R.;
Piomelli,
D.
The
endocannabinoid
system
in
brain
reward

processes.
Br
J
Pharmacol,
154
(2),
369-­-383
(2008).

575